semaglutide fda shortage As of February 21, 2025, the updated its drug list, marking the injection shortage as resolved. Semaglutide injections are no longer classified as “currently in shortage,” and both 503A Shortage update from https://www.accessdata.fda.gov/ website
Description
Participants who took Zepbound experienced significant weight loss, with many losing more than 15% of their body weight
Can I still eat carbs while taking Wegovy
What the FDA announced in April 2026 directly affects the legal availability of compounded semaglutide and tirzepatide
However, it is generally recommended to discard any reconstituted medication after 28 days to ensure potency and sterility
Adverse Effects and Safety Profile of GLP-1 Receptor Agonists The most frequently reported adverse effects of GLP-1 RAs are gastrointestinal, including nausea, vomiting, diarrhea, and constipation
